How to raise venture capital for a quantum computing startup in 2026.
Quantum computing — IBM Quantum, Google Quantum AI, IonQ, Rigetti, Quantinuum, PsiQuantum, Atom Computing, QuEra, Pasqal, Xanadu — is one of the most capital-intensive frontier categories, with 10–15 year timelines and heavy dependence on DOE, DARPA, and EU quantum-flagship non-dilutive capital.
Quantum rounds are underwritten on physical qubit count, logical qubit progress, error-correction thresholds, and DOE / DARPA / national-lab contracts — not revenue. Google's 2024 Willow chip and PsiQuantum's Illinois and Brisbane facilities reset expectations for what 'real progress' looks like.
Quantum / deep-tech dedicated: Playground Global, DCVC, Quantonation, LuxCapital, Founders Fund, Alumni Ventures, Airbus Ventures, Cambium Capital, Runa Capital, and In-Q-Tel.
Multi-stage generalists active in quantum: Sequoia (via IonQ era), a16z, T. Rowe Price (crossover), Bessemer, Coatue, and Tiger Global.
National / sovereign / strategic: BlackRock (PsiQuantum), Temasek, Mubadala, Saudi PIF, plus IBM Ventures, Google (via Google Quantum AI partnerships), Honeywell (Quantinuum), Microsoft (Azure Quantum partnerships), and Nvidia NVentures.
Superconducting (Google Willow, IBM Heron, Rigetti): fastest gate speeds, cryogenics-heavy, wire-count scaling constraints.
Trapped ion (IonQ, Quantinuum): high fidelity, slower gates, vacuum-system heavy.
Neutral atom (Atom Computing, QuEra, Pasqal): rapid scaling in qubit count, promising for error correction, younger stack.
Photonic (PsiQuantum, Xanadu): room-temperature at chip level, integrated photonics fab dependencies, longest historical timelines but fastest recent progress.
DOE Q-NEXT / QSA / SQMS quantum information science centers, DARPA Underexplored Systems for Utility-Scale Quantum Computing (US2QC), DARPA Quantum Benchmarking, NSF Quantum Leap, NIST, plus EU Quantum Flagship, UK NQCC, Australian Government Q initiatives, and Israeli Innovation Authority quantum funding. Non-dilutive can exceed dilutive by 2–5x at seed and Series A.
Investors expect concrete, measurable milestones per round: logical qubit demonstrations, below-threshold error correction, algorithmic quantum advantage on a real problem, or utility-scale coherence. PsiQuantum's Series D was gated on manufacturing progress; IonQ's early rounds were gated on gate fidelity.
Overstating qubit counts without fidelity or error rate context. Missing DOE / DARPA / EU non-dilutive stack. Vague timelines to fault tolerance. No enterprise / defense / pharma design partner. Underestimating cryogenic, vacuum, or photonic-fab capex.
Investor directory · Fundraising library · Articles A–Z · Company funding database